Published in Clinical Trials Week, November 8th, 2004
Corus 1020 is an antibiotic that has activity against a broad spectrum of Gram-negative bacteria, including Pseudomonas aeruginosa, which commonly infect the lungs of cystic fibrosis patients. Aztreonam Lysinate for Inhalation is specifically formulated to improve airway tolerability. Inhaled delivery increases the concentration of the drug...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.